In today’s ACT Brief, we look at how FDA policy is accelerating the use of de-identified real-world evidence in clinical ...
Explore how large-scale, de-identified real-world datasets enable more representative trial design, improve site selection, and support patient identification beyond the limits of traditional clinical ...
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results